$1.43
3.38% day before yesterday
Nasdaq, Dec 27, 10:17 pm CET
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Tilray, Inc. Series 2 Stock price

$1.43
+0.06 4.38% 1M
-0.30 17.34% 6M
-0.87 37.83% YTD
-0.81 36.16% 1Y
-6.18 81.21% 3Y
-14.84 91.21% 5Y
-20.96 93.61% 10Y
Nasdaq, Closing price Fri, Dec 27 2024
-0.05 3.38%
ISIN
US88688T1007
Symbol
TLRY
Sector
Industry

Key metrics

Market capitalization $1.29b
Enterprise Value $1.41b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.73
P/S ratio (TTM) P/S ratio 1.59
P/B ratio (TTM) P/B ratio 0.36
Revenue growth (TTM) Revenue growth 24.76%
Revenue (TTM) Revenue $812.04m
EBIT (operating result TTM) EBIT $-118.26m
Free Cash Flow (TTM) Free Cash Flow $-81.70m
Cash position $280.06m
EPS (TTM) EPS $-0.27
P/E forward negative
P/S forward 1.43
EV/Sales forward 1.55
Short interest 12.11%
Show more

Is Tilray, Inc. Series 2 a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,886 stocks worldwide.

Tilray, Inc. Series 2 Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

4x Buy
29%
10x Hold
71%

Analyst Opinions

14 Analysts have issued a Tilray, Inc. Series 2 forecast:

Buy
29%
Hold
71%

Financial data from Tilray, Inc. Series 2

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Aug '24
+/-
%
812 812
25% 25%
100%
- Direct Costs 658 658
9% 9%
81%
155 155
219% 219%
19%
- Selling and Administrative Expenses 144 144
36% 36%
18%
- Research and Development Expense 0.66 0.66
10% 10%
0%
9.68 9.68
117% 117%
1%
- Depreciation and Amortization 128 128
1% 1%
16%
EBIT (Operating Income) EBIT -118 -118
36% 36%
-15%
Net Profit -213 -213
85% 85%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Tilray, Inc. Series 2 directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tilray, Inc. Series 2 Stock News

Negative
Market Watch
one day ago
Investors owning cannabis stocks will no doubt hope for a reversal of fortunes in 2025 after a year of bruising losses in equity prices tied to the business of legalized marijuana in the U.S.
Neutral
The Motley Fool
5 days ago
While it's often narratives rather than numbers that cause stocks to swing in value, sometimes the most parsimonious way to summarize a company's strengths and weaknesses is to focus on a key quantitative metric or two. Numbers never tell the whole story, but they can often give investors some pretty solid hints about what's coming next.
Negative
Invezz
5 days ago
Tilray Inc (NASDAQ: TLRY) chief executive Irwin Simon expects the recreational use of cannabis to be legalised on a federal level under Donald Trump as the President of the United States. In other words, he expects legalisation to occur over the next four years.
More Tilray, Inc. Series 2 News

Company Profile

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

Head office United States
CEO Irwin Simon
Employees 2,650
Founded 2018
Website www.tilray.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today